US 8097713
Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 8097713 (Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P11/00